Table 4.
Parameters | Late-Onset Cholecystitis | No Late-Onset Cholecystitis | p-Value |
---|---|---|---|
No. of patients | 1 (7.1) | 13 (92.9) | |
Gender (M/F) | 1 (100)/0 (0) | 6 (46.2)/7 (53.8) | 0.299 |
Age (year, mean ± SD) | 80 | 80 ± 10.4 | 0.173 |
Presence of GB stone | 0 (0) | 1 (7.7) | 0.773 |
Presence of diabetes | 1 (100) | 2 (15.4) | 0.047 |
AST | 37 | 124.7 ± 183.68 | 0.374 |
ALT | 27 | 71.2 ± 88.37 | 0.233 |
TB | 0.37 | 4.8 ± 4.0 | 0.301 |
DB | 0.21 | 4.4 ± 3.57 | 0.301 |
Pre-ERCP cholangitis | 0 (0) | 8 (61.5) | 0.231 |
GB filling with contrast medium | 0 (0) | 3 (23.1) | 0.588 |
Invasion of the cystic duct orifice | 1 (100) | 7 (53.8) | 0.369 |
GB filling with contrast medium and invasion of the cystic duct | 0 (0) | 2 (15.4) | 0.672 |
Length of the common part of the Y-stent (cm) | 4 | 4 ± 1.2 | 0.267 |
Stent patent days | 321 | 96 ± 128.0 | 0.082 |
Stent obstruction | 1 (100) | 2 (15.4) | 0.047 |
Repeated procedure due to stent obstruction | 1 (100) | 2 (15.4) | 0.047 |
Survival days | 434 | 179 ± 154.0 | 0.374 |
Data are presented as mean ± SD. ERCP, endoscopic retrograde cholangiopancreatography; GB, gallbladder; AST, aspartate transaminase; ALT, alanine transaminase; TB, total bilirubin; DB, direct bilirubin.